AIPLA Committee Webinar: Israel’s Innovation Blueprint: From Idea to Impact
November 12, 2025 12:30 PM to 2:00 PM
Please join the AIPLA IP Practice in Israel Committee for a FREE member webinar:
Israel’s Innovation Blueprint: From Idea to Impact
Join us for a unique opportunity to hear directly from two of Israel’s leading voices in innovation and intellectual property at the upcoming AIPLA webinar, “Israel’s Innovation Blueprint: From Idea to Impact.” Mordechay (Moti) Sorek, Director of the Israel Patent Office, will highlight the remarkable growth of the Israel Patent Office and its recognition as an International Searching Authority for PCT applications - an achievement that underscores Israel’s increasing role in the global IP landscape. Zafrir Neuman, Chief Legal Officer of the Israel Innovation Authority, will provide insights into Israel’s high-tech ecosystem and the Israel Innovation Authority’s role in supporting R&D, innovation and global tech presence. Don’t miss this inside look at how Israel translates ideas into global impact.
Moderators:
Joel Beider, Beider IP, Chair of AIPLA IP Practice in Israel Committee
Phillip Wolfe, Morgan, Lewis & Bockius LLP, Vice Chair of AIPLA IP Practice in Israel Committee
Speakers:
Mordechay (Moti) Sorek, Director of the Israel Patent Office
Zafrir Neuman, Chief Legal Officer of the Israel Innovation Authority
This program is free for AIPLA Members. No CLE Available.
Add to:
News
-
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026.